NO is a key regulator of endothelial function (Cyr et al., 2020), and hyperlipidemia not only reduces circulating NO levels by downregulating eNOS expression but also affects related pathways through LOX-1 entry into ECs, leading to endothelial dysfunction. The gene discussed is NOS3; the disease is hyperlipidemia.